Emerging role of sirtuins on tumorigenesis: possible link between aging and cancer

키워드

참고문헌 (89)

1. Lopez-Otin, C., "The hallmarks of aging", Cell, 153, pp.1194~1217 (2013)
2. Hanahan, D., "Hallmarks of cancer: the next generation", Cell, 144, pp.646~674 (2011)
3. Hanahan, D, "The hallmarks of cancer", Cell, 100, pp.57~70 (2000)
4. Moskalev, A. A., "The role of DNA damage and repair in aging ugh the prism of Koch-like criteria", Ageing Res. Rev, 12, pp.661~684 (2012)
5. Hoeijmakers, J. H., "DNA damage, aging, and cancer", N. Engl. J. Med, 361, pp.1475~1485 (2009)
6. Blackburn, E. H., "Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging", Nat. Med, 12, pp.1133~1138 (2006)
7. Fraga, M. F, "Epigenetics and aging: the targets and the marks", Trends Genet, 23, pp.413~418 (2007)
8. Powers, E. T., "Biological and chemical approaches to diseases of proteostasis deficiency", Annu. Rev. Biochem, 78, pp.959~991 (2009)
9. Green, D. R., "Mitochondria and the autophagy-inflammation-cell death axis in organismal aging", Science, 333, pp.1109~1112 (2011)
10. Campisi, J., "Cellular senescence: when bad things happen to good cells", Nat. Rev. Mol. Cell Biol, 8, pp.729~740 (2007)
11. Rossi, D. J., "Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age", Nature, 447, pp.725~729 (2007)
12. Laplante, M., "mTOR signaling in growth control and disease", Cell, 149, pp.274~293 (2012)
13. Barzilai, N., "The critical role of metabolic pathways in aging", Diabetes, 61, pp.1315~1322 (2012)
14. Imai, S., "Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase", Nature, 403, pp.795~800 (2000)
15. Frye, R. A., "Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins", Biochem. Biophys. Res. Commun, 273, pp.793~798 (2000)
16. Baur, J. A., "Are sirtuins viable targets for improving healthspan and lifespan?", Nat. Rev. Drug Discov, 11, pp.443~461 (2012)
17. Haigis, M. C, "Mammalian sirtuins: biological insights and disease relevance", Annu. Rev. Pathol, 5, pp.253~295 (2010)
18. 이신해, "Caloric restriction and its mimetics", BMB Reports, 46(4), pp.181~187 (2013), 생화학분자생물학회
19. Du, J., "Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase", Science, 334, pp.806~809 (2011)
20. Jiang, H., "SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine", Nature, 496, pp.110~113 (2013)
21. Roth, M, "Sorting out functions of sirtuins in cancer", Oncogene (2013)[DOI]
22. Morris, B. J., "Seven sirtuins for seven deadly diseases of aging", Free Radic. Biol. Med, 56, pp.133~171 (2013)
23. Martinez-Pastor, B., "Sirtuins, metabolism, and cancer", Front Pharmacol, 3, pp.22~ (2012)[DOI]
24. Hall, J. A., "The sirtuin family's role in aging and age-associated pathologies", Clin Invest, 123, pp.973~979 (2013)
25. Dryden, S. C., "Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle", Mol. Cell Biol, 23, pp.3173~3185 (2003)
26. Serrano, L., "The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation", Genes Dev, 27, pp.639~653 (2013)
27. Wilson, J. M., "Nuclear export modulates the cytoplasmic Sir2 homologue Hst2", EMBO Rep, 7, pp.1247~1251 (2006)
28. North, B. J., "The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase", Mol. Cell, 11, pp.437~444 (2003)
29. Jing, E., "SIRT2 regulates adipocyte differentiation through FoxO1 acetylation", deacetylation, 2007, pp.6, 105~114
30. Wang, F., "SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction", Aging Cell, 6, pp.505~514 (2007)
31. Jin, Y. H., "Sirt2 interacts with 14-3-3 beta", gamma and down-regulates the activity of p53, 2008, pp.368, 690~695
32. Kim, H. S., "SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC", C activity, 2011, pp.20, 487~499
33. Jiang, W., "Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase", Mol. Cell, 43, pp.33~44 (2011)
34. Das, C., "CBP", p300-mediated acetylation of histone H3 on lysine 56, 2009, pp.459, 113~117
35. North, B. J, "Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation", J. Biol. Chem, 282, pp.19546~19555 (2007)
36. Pandithage, R., "The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility", J. Cell Biol, 180, pp.915~929 (2008)
37. Donmez, G., "SIRT1 and SIRT2: emerging targets in neurodegeneration", EMBO Mol. Med, 5, pp.344~352 (2013)
38. Outeiro, T. F., "Sirtuin 2 inhibitors rescue alpha-synuclein- mediated toxicity in models of Parkinson's disease", Science, 317, pp.516~519 (2007)
39. Narayan, N., "The NAD-dependent deacetylase SIRT2 is required for programmed necrosis", Nature, 492, pp.199~204 (2013)
40. Hiratsuka, M., "Proteomicsbased identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene", BBRC, 309, pp.558~566 (2003)
41. Inoue, T., "SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress", Oncogene, 26, pp.945~957 (2007)
42. Inoue, T., "The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation", Cell Cycle, 6, pp.1011~1018 (2007)
43. Lai, C. C., "Altered expression of SIRT gene family in head and neck squamous cell carcinoma", Tumour Biol, 34, pp.1847~1854 (2013)
44. Ong, C. A., "Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma", J. Clin. Oncol, 31, pp.1576~1582 (2013)
45. Dan, L., "The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells", Haematologica, 97, pp.551~559 (2012)
46. Liu, P. Y., "The histone deacetylase SIRT2 stabilizes Myc oncoproteins", Cell Death Differ, 20, pp.503~514 (2013)
47. Chen, J., "SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B", glycogen synthase kinase-3β, Hepatology, pp.2013, 57[DOI]
48. Yang, M. H., "HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS", Mol. Cancer Res (2013)
49. Huang, J. Y., "Mitochondrial sirtuins", Biochim. Biophys. Acta, 1804, pp.1645~1651 (2010)
50. Kim, S. C., "Substrate and functional diversity of lysine acetylation revealed by a proteomics survey", Mol. Cell, 23, pp.607~618 (2006)
51. Ahn, B. H., "A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis", Proc. Natl. Acad. Sci. U. S. A, 105, pp.14447~14452 (2008)
52. Hirschey, M. D., "SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation", Nature, 464, pp.121~125 (2010)
53. Kong, X., "Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis", PLoS One, 5, pp.e11707~ (2010)
54. Kim, H. S., "SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress", Cancer Cell, 17, pp.41~52 (2010)
55. Anderson, K. A, "Mitochondrial protein acetylation regulates metabolism", Essays Biochem, 52, pp.23~35 (2012)
56. Someya, S., "Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction", Cell, 143, pp.802~812 (2010)
57. Hebert, A. S., "Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome", Mol. Cell, 49, pp.186~199 (2013)
58. Tao, R., "Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress", Mol. Cell, 40, pp.893~904 (2010)
59. Chen, Y., "Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS", EMBO Rep, 12, pp.534~541 (2011)
60. Finley, L. W., "SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization", Cancer Cell, 19, pp.416~428 (2011)
61. Inuzuka, H., "Acetylation-dependent regulation of Skp2 function", Cell, 50, pp.179~193 (2012)
62. Finley, L. W, "Metabolic regulation by SIRT3: implications for tumorigenesis", Trends Mol. Med, 18, pp.516~523 (2012)
63. Haigis, M. C., "SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells", Cell, 126, pp.941~954 (2006)
64. Laurent, G., "SIRT4 Coordinates the Balance between Lipid Synthesis and Catabolism by Repressing Malonyl CoA Decarboxylase", Mol. Cell, 50, pp.686~698 (2013)
65. Nasrin, N., "SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells", J. Biol. Chem, 285, pp.31995~32002 (2010)
66. Yang, H., "Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival", Cell, 130, pp.1095~1107 (2007)
67. Jeong, S. M., "SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism", Cancer Cell, 23, pp.450~463 (2013)
68. Du, J., "Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase", Science, 334, pp.806~809 (2011)
69. Nakagawa, T., "SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle", Cell, 137, pp.560~570 (2009)
70. Park, J., "SIRT5-Mediated Lysine Desuccinylation Impacts Diverse Metabolic Pathways", Mol. Cell, 50, pp.919~930 (2013)
71. Jia, G., "Emerging roles of SIRT6 on telomere maintenance, DNA repair, metabolism and mammalian aging", Mol. Cell Biochem, 364, pp.345~350 (2012)
72. Jiang, H., "SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine", Nature, 496, pp.110~113 (2013)
73. Mostoslavsky, R., "Genomic instability and aging-like phenotype in the absence of mammalian SIRT6", Cell, 124, pp.315~329 (2006)
74. Michishita, E., "SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin", Nature, 452, pp.492~496 (2008)
75. Yang, B., "The sirtuin SIRT6 deacetylates H3K56Ac in vivo to promote genomic stability", Cell Cycle, 8, pp.2662~2663 (2009)
76. Kaidi, A., "Human SIRT6 promotes DNA end resection through CtIP deacetylation", Science, 329, pp.1348~1353 (2010)
77. Mao, Z., "SIRT6 promotes DNA repair under stress by activating PARP1", Science, 332, pp.1443~1446 (2011)
78. Zhong, L., "The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha", Cell, 140, pp.280~293 (2010)
79. Sebastián, C., "The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism", Cell, 151, pp.1185~1199 (2012)
80. Min, L., "Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin", Nat. Cell Biol, 14, pp.1203~1211 (2012)
81. Xiao, C., "Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice", J. Biol. Chem, 287, pp.41903~41913 (2012)
82. Marquardt, J. U., "SIRT6 dependent genetic and epigenetic alterations are associated with poor clinical outcome in HCC patients", Hepatology (2013)[DOI]
83. Bauer, I., "The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses", J. Biol. Chem, 287, pp.40924~40937 (2012)
84. Khongkow, M., "SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer.", Carcinogenesis, 34, pp.1476~1486 (2013)
85. Ford, E., "Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription", Genes Dev, 20, pp.1075~1080 (2006)
86. Vakhrusheva, O., "Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice", Circ. Res, 102, pp.703~710 (2008)
87. Barber, M. F., "SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation", Nature, 487, pp.114~118 (2012)
88. In-Soo Yoon, "Ribosomal protein S3 is phosphorylated by Cdk1", cdc2 during G2, BMB Reports, pp.2011, 44(8)[DOI]
89. Kim, J. K., "Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b", Hepatology, 57, pp.1055~1067 (2013)

관련 논문AI추천